by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme
by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme
by Lori SolomonThe U.S. Food and Drug Administration recently approved two new oral medicines to treat the sexually transmitted infection gonorrhea.The first approval is forNuzolvence(zoliflodacin) gr
by Lori SolomonThe U.S. Food and Drug Administration recently approved two new oral medicines to treat the sexually transmitted infection gonorrhea.The first approval is forNuzolvence(zoliflodacin) gr